NEW YORK, Aug. 22, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Pain Management Industry
http://www.reportlinker.com/p087375/Global-Pain-Management-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_M
This report analyzes the worldwide markets for Pain Management in US$ Million by the following Product Segments: Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players such as AstraZeneca PLC, Eli Lilly and Company, Endo Pharmaceuticals, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corp., Pfizer, Inc., Wyeth, Purdue Pharma, and Sanofi S.A. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definition and Scope of Study I-3Pain Management Pharmaceuticals I-3Pain Management Devices I-3Pain Management Services I-3II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Pain Management Market to Witness Steady Growth II-1
Factors Affecting Pain Management Industry II-1
Challenges Faced II-2
Trends and Issues II-2
Future Prospects Bright for Pain Relieving Drug Market II-2
Generic Drugs Hog the Limelight II-2
Cox II Crisis Tarnishes Industry Growth II-2
Novel Therapies to Propel Opioid and Non-Opioid Therapies II-3
Neuropathic Pain - Still an Underserved Market II-3
Cyclin-dependent kinase 5 (Cdk5) II-4
Drug Dynamics in the Migraine Market II-4
Pain Pathways - Gain a Second Look II-5
Leading Players II-5
Generics to Inundate Pain Management Drug Market Further II-5
Table 1: Leading Players in the Global Pain Management
Pharmaceuticals Market (2011): Market Share Breakdown of
Value Sales for Pfizer, Eli Lilly, Johnson & Johnson, Endo
Pharma, Novartis and Others (includes corresponding
Graph/Chart) II-6
Status of Major Pipeline Drugs for Pain Management II-6
2. PRODUCT OVERVIEW II-7Pain Management: An Overview II-7Managing Pain II-7What is Pain? II-7Assessment of Pain II-8Pain Management II-8Pain Management for Neonates II-9Pain Management in Kids II-9Pain Management in Older Adult Surgical Patients II-9Pain Therapeutics - An Introduction II-10Treatment of Pain II-11Pharmacologic Method II-11Non-pharmacological Method II-12Invasive Procedures II-12Palliative Care II-13Alternative Methods II-13Acupuncture II-13Biofeedback II-14Bioelectromagnetic Therapy II-14Biomagnetism and Magnetotherapy II-14Guided Imagery II-14Manual/Massage Therapies II-14Aromatherapy Massage II-14Swedish Massage II-15Deep Tissue Massage II-15Neuromuscular Therapy II-15Myofascial Release II-15Manual Lymph Drainage II-15Cranial Sacral Therapy II-15Reflexology II-16Naturopathy II-16Relaxation Therapy II-17Transcendental Meditation II-17Classification of Pain II-17Acute Pain II-17Postoperative pain II-17Labor pain II-18Visceral pain II-18Migraine II-18Treatment of Migraine II-18Chronic Pain II-19Cancer pain II-19Back Pain II-19Neuropathic Pain II-20Arthritic Pain II-20HIV-Related Pain II-20Diabetic Neuropathy II-21Osteo-and Rheumatoid Arthritis Pain II-22Pain Management Products and Services II-22Pain Management Pharmaceuticals II-22Over-the-counter Drugs II-22Acetaminophen II-22Aspirin II-22Ibuprofen II-22Ketoprofen II-23Naproxen II-23Pramoxine II-23Counterirritants II-23Triethanolamine Salicylate (Trolamine) II-23Prescription Drugs II-24Non-steroidal Anti-Inflammatories (NSAIDs) II-24Non-opioid Analgesics II-24Opioid Analgesics II-24Pain Management Devices II-26Electrical Spinal Cord Stimulators II-26Electrical Stimulus Devices II-27Transcutaneous Electric Nerve Stimulators (TENS) II-27Patient-Controlled Analgesia Infusion Devices II-27Pain Management Services II-27Home Care/Providence Home Health II-27Providence Hospices II-28Pain Management Centers and Clinics II-28Pain Rehabilitation Programs II-28
3. REGULATORY ENVIRONMENT II-29
OTC Painkillers to Carry Conspicuous Safety Warnings II-29
Federal Regulatory Norms of Controlled Substances II-29
DEA Regulations II-29
4. PRODUCT INNOVATIONS/INTRODUCTIONS II-31Venus Remedies to Unveil Aceclofenac OD II-31Sandoz International Launches Metaxalone Tablets in US II-31Covidien Unveils EXALGO™ Extended-Release Tablets II-31Bresslergroup Develops Dental Vibe for Pain-Free DentalInjections II-32Competitive Technologies Launches Calmare® Medical Device II-32Victory Pharma Unveils Naprelan Dose Card II-32BIOLASE Technology Launches Diolase 10™ Diode Laser II-33Dr. Reddy's Laboratories Unveils Finrid Transdermal Patch II-33Cumberland Pharmaceuticals Unveils Caldolor® in US II-33Tenscare Launches Iglove II-34Piramal Launches BioElectronics' ActiPatch in India II-34Victory Pharma to Introduce Supplementary NAPRELAN Products II-34
5. PRODUCT INNOVATIONS/INTRODUCTIONS - A HISTORIC PERSPECTIVE BUILDER II-36
Lannett Unveils Two New Products II-36
Glenmark Rolls Out Morphine Oral Solution in the US II-36
Acrux Introduces New NSAID Formulations II-36
Amrutanjan Healthcare Relaunches Amrutanjan Pain Balm II-36
ConvaTec Introduces SUR-FIT Natura® Low-Pressure Adaptor II-36
Cosman Medical Launches G4 Four-Output RF Generator II-37
Origin BioMed Unveils Neuragen II-37
Biotanika Health Rolls Out Natural Product Range II-37
B. Braun Medical Introduces Curlin 6000 CMS II-37
Dynatronics Launches DynaPro Spinal Health System II-37
ProEthic Pharmaceuticals Unveils Ibudone II-38
Endo Pharmaceuticals to Introduce New Dosage Strengths of
OPANA®ER II-38
Dr. Reddy's Laboratories Unveils Supanac II-38
Troikaa Pharmaceuticals Rolls Out DYNAPAR AQ 1ml II-38
Janssen-Cilag International to Launch IONSYS™ II-39
Mallinckrodt Introduces Novel Pain Relieving Agent II-39
Shionogi Unveils Cancer Pain Management Drug II-39
NeuroTherm Launches RF Generators for Treatment of Heel Pain II-39
McNeil Brings Chewable TYLENOL® GoTabs Tablets II-40
Barr Unveils Generic Version of ACTIQ® II-40
Orthofix Unveils e-PainCare II-40
Organon Innovates Org 25969 II-40
Orthofix's BREG Division Launches Polar Care Motorized Cold
Therapy System II-40
Zynex Develops New Pain Management Device II-41
6. RECENT INDUSTRY ACTIVITY II-42Grünenthal's Tapentadol Clears European Decentralised Procedure II-42Stryker to Acquire Pain-Management Device Unit of BostonScientific II-42Axxess Pharma to Ink License Agreement for a New PrescriptionDrug II-42Endo Pharmaceuticals Acquires HealthTronics II-43Purdue Pharma Secures FDA Approval for Transdermal System II-43Discus Acquisition Takes Over Outstanding Shares of JavelinPharmaceuticals II-43Cannabis Science to Acquire Montana Pain Management II-43Roxro Pharma Receives FDA Approval for SPRIX™ Nasal Spray II-44Ralfinamide Fails to Show Benefits in Phase IIb Trial II-44NeuroTherm Acquires Smith & Nephew's Interventional Spine PainManagement Assets II-44Horizon Therapeutics Merges with Nitec Pharma II-45Gentiva Takes Over Heart to Heart Hospice II-45Millennium Laboratories Inks National Agreement with Aetna II-45PatientsLikeMe Takes Over ReliefInsite.com II-46TeamHealth Hospital Staffing Firm Acquires Anesthetix Management II-46CombinatoRx Merges with Neuromed Pharmaceuticals II-46Roche Licenses P2X31 Receptor Program to Afferent Pharmaceuticals II-47Lannett Obtains FDA approval for Producing HydromorphoneHydrochloride Tablets II-47Anesiva Inks an Asset Purchase Agreement with PowderJectTechnologies II-47Millennium Laboratories Inks Agreement with Three RiversProvider Network II-47Cumberland Pharmaceuticals Partners with Phebra to PromoteCaldolor® II-48Sciele Pharma Acquires Addrenex Pharmaceuticals II-48Bioniche Pharma Acquires Injectable Drugs from Xanodyne II-48NeurogesX Obtains FDA Approval for Qutenza™ II-49Cerimon Acquires Development and Commercialization Rights forDiclofenac in Europe II-49Hydra Biosciences Collaborates with Cubist II-49Zambon Spa Inks a Licensing Agreement with Indena Spa II-50Pfizer Acquires Wyeth II-50B. Braun Bags Contract from HealthTrust Purchasing Group II-50QRxPharma Enters into Partnership with Patheon to ProduceClinical Supplies II-51Kimberly-Clark to Acquire I-Flow II-51Kimberly-Clark Takes Over Pain Management Business of BaylisMedical II-52WraSer Pharmaceuticals Purchases Trezix® from e5 Pharma II-52TorreyPines Therapeutics Merges with Raptor Therapeutics II-52GSK Enters into Agreement with Dr Reddy's Laboratories II-53Patterson Medical Acquires DJO's Supply Catalog andRehabilitation Equipment Business II-53Mallinckrodt Acquires Licensing Rights from Neuromed II-53Nuvo Research Enters into Licensing Agreement with Mallinckrodt II-53Bederra Plans to Take Over Neogenex II-54Z-Cube Inks Deal with Yissum II-54XenaCare Acquires US License for Homeopathic Treatment II-54Symbios Ropes in Distributors to Market Pain ManagementProducts Across US II-54Teikoku Pharma Takes Over Travanti Pharma II-54Diamyd Licenses Endomorphin Technology II-55Competitive Technologies and Life Episteme Enters into anAgreement II-55Bederra Enters into Collaboration with Pain Management Center II-55Javelin Pharmaceuticals Signs Agreement with Therabel Pharma II-56Biotanika Inks Deal with Xymogen II-56HSR Clears Solvay Pharmaceuticals and Depomed's LicensingAgreement II-56BioDelivery Sciences and Meda Ink an Agreement II-56Endo Pharmaceuticals to Take Over Indevus Pharmaceuticals II-56
7. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-57
Actavis US Acquires Kadian II-57
Labopharm Receives Approval from U.S. Food and Drug
Administration II-57
Albert Acquisition Acquires Alpharma II-57
Sosei Group Re-acquires Commercialization Rights for AD 923 II-57
Sun Pharmaceutical Industries Purchases Chattem Chemicals II-57
Piramal Healthcare Inks Agreement with Minrad International II-58
AgION Technologies and Stryker's Instruments Division Enter
into Agreement II-58
Elder Pharmaceuticals and Global Energy Medicines Sign Agreement II-58
Wound Management Technologies to Take Over BioPharma
Management Technologies II-58
NovaMed Purchases Stake in The Center for Specialized Surgery II-59
RxElite Ends Agreement with Minrad International II-59
Johnson & Johnson Receives FDA Approval for Tapentadol II-59
Mundipharma International and Purdue Pharma Ink Alliance with
Infinity II-59
Zynex Obtains CE Mark for IF8100 and IF8000 Pain-Managing Devices II-59
Competitive Technologies and Able Global Healthcare Ink an
Agreement II-59
National Surgical Hospitals Inks New Joint Venture II-60
Getting Ready and Winston Laboratories Merge II-60
Competitive Technologies and Biogene Pharma Ink an Agreement II-60
MEKT and ProtoKinetix Enter into Agreement II-60
Tronics Microsystems Takes Over MedTech Development II-61
NSC Purchases Ardmore Regional Surgery Center and Kenwood
Surgery Center II-61
Mallinckrodt and Purdue Pharma Sign Agreement II-61
Javelin Pharmaceuticals and Baxter Healthcare Enter into
Agreement II-61
Competitive Technologies and Excel Life Sciences Ink an Agreement II-61
Theragenics to Buy NeedleTech Products II-62
Wyeth Consumer Healthcare Inks Agreement with Procter & Gamble II-62
NovaMed Purchases Majority Stake in Interventional Pain
Management Center II-62
Option Care Enterprises Takes Over CuraScript Infusion Pharmacy II-62
Eli Lilly Obtains FDA Approval for Cymbalta® II-63
Curlin Medical Receives Contract from Premier II-63
EUSA Pharma Acquires Cytogen II-63
American Oriental Enters into Alliance with China Aoxing
Pharmaceutical II-63
Treximet Bags Approval from FDA II-64
LMA International Takes Over Breg's Pain Management Operations II-64
Hospira and HealthTrust Purchasing Group Enter into Agreement II-64
Hebei Aoxing Pharmaceutical Purchases Shijiazhuang Lerentang
Pharmaceutical II-64
Bederra Signs Letter of Intent with Lumar Diagnostic Imaging II-65
Integrated Pain Solutions and Devon Health Services Sign
Agreement II-65
Maneesh Pharmaceuticals Purchases Smyle II-65
Eli Lilly and Glenmark Pharmaceuticals Ink an Agreement II-65
Orexo Takes Over Biolipox II-66
ReAble Therapeutics to Acquire Shares of IOMED II-66
Integra LifeSciences Buys Assets of Pain Management Operations
of Physician Industries II-66
CeNeS Obtains IND Clearance for M6G from FDA II-66
Infinity Acquisition Takes Over Life Without Pain II-67
Neuromed to Acquire US Rights for Oros Hydromorphone from Alza II-67
China Aoxing to Acquire Chinese Pharmaceutical Company,
Shijiazhuang Le Ren II-68
Vyteris Holdings to Acquire Lehigh Valley Technologies II-68
Younger America Pockets Life Without Pain II-68
PainCare Divests Center for Pain Management II-69
Grand Slam Acquires IOMED II-69
Ligand Accomplishes Divesture of AVINZA II-69
CeNeS and Ergomed Collaborate for Phase II Trials of NMDA
Antagonist CNS 5161 II-69
Sorenson Secures Approval to Market Ambulatory Infusion Pump
in China II-69
PainCare Pockets CPMASC II-70
Moog Takes Over Mckinley Medical Corp II-70
PainCare Acquires REC, CareFirst Medical Associates II-70
CLL Pharma Acquires Synt:em II-70
AstraZeneca Partners with Pozen to Bring Novel Pain Management
Therapy II-70
Great Outdoors Acquires Somatic Systems Institute II-71
PainCare Partners with Solstice Neurosciences to Offer Pain
Management in CD II-71
Elan Confers Eisai with European Rights of Prialt II-71
Evotec Partners with Apeiron Biologics to Bring Novel Pain
Therapy II-71
Alpaca Enterprises Acquires Neuroscience Therapy Corp II-71
PainCare Holdings Acquires Desert Pain Medicine Group. II-72
Wex Pharma Inks Agreement With Boston Children's Hospital II-72
Glenmark Inks Agreement with LVT to Market Pain Management
Products II-72
EKR Attains North American Marketing Rights for Gelclair II-72
Grand Slam Acquires Cefar Medical II-72
Omeros Acquires Nura II-72
Hospira Inks Agreement with Premier II-73
Pain Therapeutics Enters into Alliance with King Pharmaceuticals II-73
Corgentech Merges with AlgoRx II-73
Elder Pharmaceuticals Ventures into the Indian Pain Management
Market II-73
Xanodyne Acquires Pharmaceutical Assets of aaiPharma II-73
Pro-Dex Acquires Dental Technology From IntraVantage II-74
Encore Medical Acquires Compex Technologies II-74
Sosei Acquires Arakis II-74
Corgentech Signs Definitive Merger Agreement With AlgoRx II-74
Elder Pharmaceuticals Enters into Marketing Agreement with TRB
Chemedica II-75
University Pain Management Center Signs Agreement with Somnia II-75
Entelos and Organon to Extend Rheumatoid Arthritis (RA)
Collaboration II-75
NovaMed Establishes a New Pain Management Center at Indiana II-75
8. FOCUS ON SELECT KEY PLAYERS II-76AstraZeneca Plc. (UK) II-76Eli Lilly and Company (USA) II-76Endo Pharmaceuticals (USA) II-76GlaxoSmithkline Plc. (UK) II-76Johnson & Johnson (USA) II-77Merck & Co., Inc. (USA) II-77Novartis Pharmaceuticals Corp. (USA) II-78Pfizer, Inc. (USA) II-78Wyeth (USA) II-78Purdue Pharma (USA) II-79Sanofi S.A (France) II-79
9. GLOBAL MARKET PERSPECTIVE II-80
Table 2: World Recent Past, Current & Future Analysis for Pain
Management by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2009 through 2017(includes
corresponding Graph/Chart) II-80
Table 3: World Historic Review for Pain Management byGeographic Region - US, Canada, Japan, Europe, Asia- Pacific(excluding Japan), Latin America, and Rest of World MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008(includes correspondingGraph/Chart) II-81
Table 4: World 15-Year Perspective for Pain Management by
Geographic Region - Percentage Breakdown of Annual Revenue for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2003, 2011 &
2017 (includes corresponding Graph/Chart) II-82
Table 5: World Recent Past, Current & Future Analysis for PainManagement Pharmaceuticals by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualRevenue Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart) II-83
Table 6: World Historic Review for Pain Management
Pharmaceuticals by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2003 through 2008(includes
corresponding Graph/Chart) II-84
Table 7: World 15-Year Perspective for Pain ManagementPharmaceuticals by Geographic Region - Percentage Breakdown ofAnnual Revenue for US, Canada, Japan, Europe, Asia-Pacific(Excluding Japan), Latin America and Rest of World Markets forYears 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-85
Table 8: World Recent Past, Current & Future Analysis for Pain
Management Devices by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2009 through 2017(includes
corresponding Graph/Chart) II-86
Table 9: World Historic Review for Pain Management Devices byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008(includes correspondingGraph/Chart) II-87
Table 10: World 15-Year Perspective for Pain Management
Devices by Geographic Region - Percentage Breakdown of Annual
Revenue for US, Canada, Japan, Europe, Asia- Pacific
(ex2008cluding Japan), Latin America and Rest of World Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-88
Table 11: World Recent Past, Current & Future Analysis forPain Management Services by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin Americaand Rest of World Markets Independently Analyzed with AnnualRevenue Figures in US$ Million for Years 2009 through2017(includes corresponding Graph/Chart) II-89
Table 12: World Historic Review for Pain Management Services
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008(includes corresponding
Graph/Chart) II-90
Table 13: World 15-Year Perspective for Pain ManagementServices by Geographic Region - Percentage Breakdown of AnnualRevenue for US, Canada, Japan, Europe, Asia- Pacific(excluding Japan), Latin America and Rest of World Markets forYears 2003, 2011 & 2017 (includes corresponding Graph/Chart) II-91III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Pain Statistics in the US III-1
Industry Overview III-1
Pain Management Therapies on the Rise III-2
Opioids Pain Management Market to Garner Sizeable Growth III-2
Safety Concerns Restrict Large Scale Adoption III-2
Measures to Thwart Drug Abuse III-3
Market for Cancer Pain Therapeutics III-3
Leading Players/Brands III-3
Table 14: Leading OTC Pain Relievers in the US Market for
Pain Management (2011) - Percentage Breakdown of Value
Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol
PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin
Migraine, Private label, and Others (includes corresponding
Graph/Chart) III-3
Table 15: Leading Oral Pain Relievers in the US Market forPain Management (2011) - Percentage Breakdown of ValueSales by Brand for Orajel, Anbesol, Baby Orajel, ColgatePeroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin,Orajel Mouth Aid, and Others (includes correspondingGraph/Chart) III-4B.Market Analytics III-5Table 16: The US Recent Past, Current & Future Analysis forPain Management by Product Segment - Pain ManagementPharmaceuticals, Pain Management Devices and Pain ManagementServices Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-5
Table 17: The US Historic Review for Pain Management by
Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-6
Table 18: The US 15-Year Perspective for Pain Management byProduct Segment - Percentage Breakdown of Annual Revenue forPain Management Pharmaceuticals, Pain Management Devices andPain Management Services Markets for Years 2003, 2011 & 2017(Includes corresponding graphs/chart) III-7
2. CANADA III-8
Market Analytics III-8
Table 19: Canadian Recent Past, Current & Future Analysis
for Pain Management by Product Segment - Pain Management
Pharmaceuticals, Pain Management Devices and Pain Management
Services Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-8
Table 20: Canadian Historic Review for Pain Management byProduct Segment - Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) III-9
Table 21: Canadian 15-Year Perspective for Pain Management
by Product Segment - Percentage Breakdown of Annual Revenue
for Pain Management Pharmaceuticals, Pain Management Devices
and Pain Management Services Markets for Years 2003, 2011
&2017 (includes corresponding Graph/Chart) III-10
3. JAPAN III-11Market Analytics III-11Table 22: Japanese Recent Past, Current & Future Analysisfor Pain Management by Product Segment - Pain ManagementPharmaceuticals, Pain Management Devices and Pain ManagementServices Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-11
Table 23: Japanese Historic Review for Pain Management by
Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-12
Table 24: Japanese 15-Year Perspective for Pain Managementby Product Segment - Percentage Breakdown of Annual Revenuefor Pain Management Pharmaceuticals, Pain Management Devicesand Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart) III-13
4. EUROPE III-14
Market Analytics III-14
Table 25: European Recent Past, Current & Future Analysis
for Pain Management by Geographic Region - France, Germany,
Italy, UK, Spain, Russia & Rest of Europe Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-14
Table 26: European Historic Review for Pain Management byGeographic Region - France, Germany, Italy, UK, Spain,Russia & Rest of Europe Markets Independently Analyzed withAnnual Revenue Figures in US$ Million for Years 2003 through2008 (includes corresponding Graph/Chart) III-15
Table 27: European 15-Year Perspective for Pain Management
by Geographic Region - Percentage Breakdown of Annual
Revenue for France, Germany, Italy, UK, Spain, Russia & Rest
of Europe Markets for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) III-16
Table 28: European Recent Past, Current & Future Analysisfor Pain Management by Product Segment - Pain ManagementPharmaceuticals, Pain Management Devices and Pain ManagementServices Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-17
Table 29: European Historic Review for Pain Management by
Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed With Annual Revenue Figures in US$
Million for Years 2003 through 2008(includes corresponding
Graph/Chart) III-18
Table 30: European 15-Year Perspective for Pain Managementby Product Segment - Percentage Breakdown of Annual Revenuefor Pain Management Pharmaceuticals, Pain Management Devicesand Pain Management Services Markets for Years 2003, 2011 &2017 (includes corresponding Graph/Chart) III-19
4a. FRANCE III-20
Market Analytics III-20
Table 31: French Recent Past, Current & Future Analysis for
Pain Management by Product Segment - Pain Management
Pharmaceuticals, Pain Management Devices and Pain Management
Services Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-20
Table 32: French Historic Review for Pain Management byProduct Segment - Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008(includes correspondingGraph/Chart) III-21
Table 33: French 15-Year Perspective for Pain Management by
Product Segment - Percentage Breakdown of Annual Revenue for
Pain Management Pharmaceuticals, Pain Management Devices and
Years Pain Management Services Markets for Years 2003, 2011 &
2017 (includes corresponding Graph/Chart) III-22
4b. GERMANY III-23Market Analytics III-23Table 34: German Recent Past, Current & Future Analysis forPain Management by Product Segment - Pain ManagementPharmaceuticals, Pain Management Devices and Pain ManagementServices Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-23
Table 35: German Historic Review for Pain Management by
Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-24
Table 36: German 15-Year Perspective for Pain Management byProduct Segment - Percentage Breakdown of Annual Revenue forPain Management Pharmaceuticals, Pain Management Devices andPain Management Services Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-25
4c. ITALY III-26
Market Analytics III-26
Table 37: Italian Recent Past, Current & Future Analysis for
Pain Management by Product Segment - Pain Management
Pharmaceuticals, Pain Management Devices and Pain Management
Services Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-26
Table 38: Italian Historic Review for Pain Management byProduct Segment - Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) III-27
Table 39: Italian 15-Year Perspective for Pain Management by
Product Segment - Percentage Breakdown of Annual Revenue for
Pain Management Pharmaceuticals, Pain Management Devices and
Pain Management Services Markets for Years 2003, 2011 & 2017
(includes corresponding Graph/Chart) III-28
4d. THE UNITED KINGDOM III-29A.Market Analysis III-29Key Statistics Related to Pain Management in the UK III-29B.Market Analytics III-30Table 40: The UK Recent Past, Current & Future Analysis forPain Management by Product Segment -Pain ManagementPharmaceuticals, Pain Management Devices and Pain ManagementServices Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-30
Table 41: The UK Historic Review for Pain Management by
Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-31
Table 42: The UK 15-Year Perspective for Pain Management byProduct Segment - Percentage Breakdown of Annual Revenue forPain Management Pharmaceuticals, Pain Management Devices andPain Management Services Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-32
4e. SPAIN III-33
Market Analytics III-33
Table 43: Spanish Recent Past, Current & Future Analysis for
Pain Management by Product Segment - Pain Management
Pharmaceuticals, Pain Management Devices and Pain Management
Services Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-33
Table 44: Spanish Historic Review for Pain Management byProduct Segment - Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) III-34
Table 45: Spanish 15-Year Perspective for Pain Management by
Product Segment - Percentage Breakdown of Annual Revenue for
Pain Management Pharmaceuticals, Pain Management Devices and
Pain Management Services Markets for Years 2003, 2011 & 2017
(includes corresponding Graph/Chart) III-35
4f. RUSSIA III-36Market Analytics III-36Table 46: Russian Recent Past, Current & Future Analysis forPain Management by Product Segment - Pain ManagementPharmaceuticals, Pain Management Devices and Pain ManagementServices Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-36
Table 47: Russian Historic Review for Pain Management by
Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-37
Table 48: Russian 15-Year Perspective for Pain Management byProduct Segment - Percentage Breakdown of Annual Revenue forPain Management Pharmaceuticals, Pain Management Devices andPain Management Services Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart) III-38
4g. REST OF EUROPE III-39
Market Analytics III-39
Table 49: Rest of Europe Recent Past, Current & Future
Analysis for Pain Management by Product Segment -Pain
Management Pharmaceuticals, Pain Management Devices and Pain
Management Services Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) III-39
Table 50: Rest of Europe Historic Review for Pain Managementby Product Segment - Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) III-40
Table 51: Rest of Europe 15-Year Perspective for Pain
Management by Product Segment - Percentage Breakdown of
Annual Revenue for Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets for
Years 2003, 2011 &2017 (includes corresponding Graph/Chart) III-41
5. ASIA-PACIFIC III-42A.Market Analysis III-42India III-42B.Market Analytics III-42Table 52: Asia-Pacific Recent Past, Current & FutureAnalysis for Pain Management by Product Segment -PainManagement Pharmaceuticals, Pain Management Devices and PainManagement Services Markets Independently Analyzed withAnnual Revenue Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) III-42
Table 53: Asia-Pacific Historic Review for Pain Management
by Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-43
Table 54: Asia-Pacific 15-Year Perspective for PainManagement by Product Segment - Percentage Breakdown ofAnnual Revenue for Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services Markets forYears 2003, 2011 & 2017 (includes corresponding Graph/Chart) III-44
6. LATIN AMERICA III-45
Market Analytics III-45
Table 55: Latin American Recent Past, Current & Future
Analysis for Pain Management by Product Segment -Pain
Management Pharmaceuticals, Pain Management Devices and Pain
Management Services Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2009 through
2017(includes corresponding Graph/Chart) III-45
Table 56: Latin American Historic Review for Pain Managementby Product Segment - Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2003 through 2008(includes correspondingGraph/Chart) III-46
Table 57: Latin American 15-Year Perspective for Pain
Management by Product Segment - Percentage Breakdown of
Annual Revenue for Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets for
Years 2003, 2011 & 2017 (includes corresponding Graph/Chart) III-47
7. REST OF WORLD III-48Market Analytics III-48Table 58: Rest of World Recent Past, Current & FutureAnalysis for Pain Management by Product Segment - PainManagement Pharmaceuticals, Pain Management Devices and PainManagement Services Markets Independently Analyzed withAnnual Revenue Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) III-48
Table 59: Rest of World Historic Review for Pain Management
by Product Segment - Pain Management Pharmaceuticals, Pain
Management Devices and Pain Management Services Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2003 through 2008(includes corresponding
Graph/Chart) III-49
Table 60: Rest of World 15-Year Perspective for PainManagement by Product Segment - Percentage Breakdown ofAnnual Revenue for Pain Management Pharmaceuticals, PainManagement Devices and Pain Management Services Markets forYears 2003, 2011 & 2017 (includes corresponding Graph/Chart) III-50IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 117 (including Divisions/Subsidiaries - 133)
------------------------------------------Region/Country Players------------------------------------------The United States 82Canada 3Japan 7Europe 32France 4Germany 4The United Kingdom 10Italy 2Rest of Europe 12Asia-Pacific (Excluding Japan) 7Latin America 1Middle East 1------------------------------------------
To order this report:General Medicine and Specialty Medicine Industry: Global Pain Management Industry
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article